LeadIQ logo
Learn more at LeadIQ.com

Insights

Cutting-Edge RNA Therapeutics Nutcracker Therapeutics is a pioneering RNA therapeutics company with a cutting-edge platform that accelerates the development of life-changing RNA therapies. This technology advantage positions the company as a leader in the biotechnology research industry, presenting a prime opportunity for partnerships with pharma companies seeking innovative solutions.

Investment and Expansion Nutcracker Therapeutics has secured significant funding, totaling $167M, and has strategically expanded its pipeline with the launch of mRNA drug candidate NTX-470. This financial stability and focus on new developments indicate a company poised for growth, making it an attractive target for investment opportunities and collaborations.

Key Hires for Scientific Excellence With the recent hire of Samuel Deutsch as chief scientific officer, Nutcracker Therapeutics emphasizes its commitment to scientific excellence. Deutsch's industry experience and expertise signal a strong leadership team driving cutting-edge research, making the company an ideal partner for scientific collaborations and joint ventures.

Strategic Board Appointments The appointment of Thomas J. Dietz, Ph.D., to Nutcracker Therapeutics' board of directors further enhances the company's strategic direction. Dietz's expertise brings valuable insights to board discussions, enhancing the company's decision-making processes. This strategic move opens doors for alliances with organizations interested in board-level engagements.

Competitive Landscape and Market Trends In a landscape with similar biotech companies like Atomwise, CytoReason, and LabGenius, Nutcracker Therapeutics stands out with its proprietary RNA therapeutic platform. Understanding market trends and the competitive landscape positions sales professionals to highlight Nutcracker's unique offerings to potential partners and investors.

Similar companies to Nutcracker Therapeutics

Nutcracker Therapeutics Tech Stack

Nutcracker Therapeutics uses 8 technology products and services including Shopify, Microsoft Outlook, Twitter Emoji (Twemoji), and more. Explore Nutcracker Therapeutics's tech stack below.

  • Shopify
    E-commerce
  • Microsoft Outlook
    Email
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Font Awesome
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • jQuery
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • Smartsheet
    Project Management

Media & News

Nutcracker Therapeutics's Email Address Formats

Nutcracker Therapeutics uses at least 1 format(s):
Nutcracker Therapeutics Email FormatsExamplePercentage
First.Last@nutcrackerx.comJohn.Doe@nutcrackerx.com
80%
Last@nutcrackerx.comDoe@nutcrackerx.com
17%
FLast@nutcrackerx.comJDoe@nutcrackerx.com
2%
First.L@nutcrackerx.comJohn.D@nutcrackerx.com
1%

Frequently Asked Questions

Where is Nutcracker Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Nutcracker Therapeutics's main headquarters is located at 5858 Horton St Emeryville, California 94608 US. The company has employees across 2 continents, including North AmericaAsia.

What is Nutcracker Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Nutcracker Therapeutics's official website is nutcrackerx.com and has social profiles on LinkedIn.

How much revenue does Nutcracker Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2024, Nutcracker Therapeutics's annual revenue reached $15M.

What is Nutcracker Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Nutcracker Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Nutcracker Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2024, Nutcracker Therapeutics has approximately 114 employees across 2 continents, including North AmericaAsia. Key team members include Chief Scientific Officer: S. D.Vice President Of Manufacturing: J. K.President: H. A.. Explore Nutcracker Therapeutics's employee directory with LeadIQ.

What industry does Nutcracker Therapeutics belong to?

Minus sign iconPlus sign icon
Nutcracker Therapeutics operates in the Biotechnology Research industry.

What technology does Nutcracker Therapeutics use?

Minus sign iconPlus sign icon
Nutcracker Therapeutics's tech stack includes ShopifyMicrosoft OutlookTwitter Emoji (Twemoji)Font AwesomeGoogle CloudjQueryjQuery MigrateSmartsheet.

What is Nutcracker Therapeutics's email format?

Minus sign iconPlus sign icon
Nutcracker Therapeutics's email format typically follows the pattern of . Find more Nutcracker Therapeutics email formats with LeadIQ.

How much funding has Nutcracker Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2024, Nutcracker Therapeutics has raised $167M in funding. The last funding round occurred on Mar 14, 2022 for $167M.

When was Nutcracker Therapeutics founded?

Minus sign iconPlus sign icon
Nutcracker Therapeutics was founded in 2018.
Nutcracker Therapeutics

Nutcracker Therapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

Nutcracker Therapeutics is an RNA therapeutics company that has combined the power of advanced engineering with high-precision biosynthesis to deploy a complete RNA therapeutics platform. Armed with this high-tech advantage, we have developed a wholly owned pipeline of RNA therapeutic programs and established partnership initiatives with top clinical investigators at several leading institutions across the globe. With our platform’s ability to accelerate the development of life-changing RNA therapeutics, we seek to advance breakthrough RNA therapies at high velocity through all stages of development across a variety of indications. Our technology platform has the potential to significantly reduce costs and cycle times for RNA therapeutic development, with dramatic advantages in capacity scaling and point-of-care delivery over other RNA manufacturing approaches.

Section iconCompany Overview

Headquarters
5858 Horton St Emeryville, California 94608 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $167M

    Nutcracker Therapeutics has raised a total of $167M of funding over 4 rounds. Their latest funding round was raised on Mar 14, 2022 in the amount of $167M.

  • $10M$50M

    Nutcracker Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $167M

    Nutcracker Therapeutics has raised a total of $167M of funding over 4 rounds. Their latest funding round was raised on Mar 14, 2022 in the amount of $167M.

  • $10M$50M

    Nutcracker Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.